Aussie scientists uncover surprising twists in malaria, breast cancer research

Two recent Australian scientific studies have unveiled unexpected insights into the complex ways our bodies respond to diseases like malaria and breast cancer. These discoveries challenge the prevailing notion that disease responses are straightforward.

In the first study, researchers at the Walter and Eliza Hall Institute of Medical Research developed a novel malaria vaccination strategy. By pairing malaria parasites delivered by mosquitoes with antimalarial compounds, they were able to trap the parasites in the liver before they could spread to the bloodstream and cause infection.

This "vaccinate and boost naturally" approach provided protection to mice for up to two years. The researchers believe that later mosquito bites could potentially reinforce this immunity, suggesting a possible new approach for malaria prevention in endemic regions. However, the findings are still in early stages, and more research is needed to develop a long-acting injectable version of the drug compounds.

In a separate discovery from the Peter MacCallum Cancer Centre, scientists investigated the retinoblastoma (Rb) protein, a well-known tumor suppressor that helps prevent uncontrolled cell division. The study, published in Nature, revealed that Rb can also activate genes that respond to oestrogen. Some of these oestrogen-responsive genes may help cancer cells survive treatment and continue to grow.

This unexpected dual role of Rb could explain why certain cancer treatments, such as CDK4/6 inhibitors, work well when combined with endocrine therapy for hormone receptor-positive breast cancer. However, when tumors become resistant to endocrine therapy, the oestrogen-driven signals that Rb can activate may persist, undermining the effectiveness of CDK4/6 inhibitors.

Researchers hope that understanding this new aspect of Rb's function could lead to the development of drug combinations that delay treatment resistance and maintain effectiveness over a longer period.